Hims & Hers Health (HIMS) News Today $27.80 -0.14 (-0.49%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Hims & Hers: Ready To Outperform FurtherJanuary 20 at 4:11 PM | seekingalpha.comHims & Hers Health: A Stock to Trade or Own?HIMS achieved remarkable growth in 2024 but now faces challenges in 2025, raising the question of whether it suits traders better than long-term investors.January 20 at 7:00 AM | marketbeat.comSBC Medical Group (NASDAQ:SBC) vs. Hims & Hers Health (NYSE:HIMS) Financial ContrastJanuary 20 at 1:15 AM | americanbankingnews.comOak Ridge Investments LLC Reduces Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)Oak Ridge Investments LLC decreased its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 30.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 86,342 shares of the company's stock afterJanuary 19 at 7:33 AM | marketbeat.comHims & Hers Health (NYSE:HIMS) Sees Large Volume Increase - What's Next?January 19 at 4:03 AM | americanbankingnews.comHims & Hers falls -6.5%January 18 at 8:50 AM | markets.businessinsider.comLake Street Private Wealth LLC Increases Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)Lake Street Private Wealth LLC boosted its stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 28.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 133,168 shares of the company's stock after purchaJanuary 18 at 8:13 AM | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Short Interest UpdateHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totalling 52,120,000 shares, an increase of 21.3% from the December 15th total of 42,970,000 shares. Approximately 29.4% of the shares of the stock are short sold. Based on an average daily volume of 16,430,000 shares, the short-interest ratio is presently 3.2 days.January 17 at 11:21 PM | marketbeat.comCautious Outlook on Hims & Hers Health Amid Regulatory Risks and Revenue ConcernsJanuary 17 at 5:49 PM | markets.businessinsider.comHims & Hers Health down 3% after BoA says Q4 revenue could be a missJanuary 17 at 5:49 PM | msn.comHims & Hers Health (NYSE:HIMS) Sees Unusually-High Trading Volume - Should You Buy?Hims & Hers Health (NYSE:HIMS) Sees Large Volume Increase - Time to Buy?January 17 at 1:13 PM | marketbeat.comWhy Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped TodayJanuary 17 at 11:37 AM | fool.comTop Growth Picks: 3 Low-Cost Stocks That Could Double in Value (HIMS)Here are three low-priced stocks you can buy today that are positioned in sector that make them solid choices to double in 2025January 17 at 8:15 AM | marketbeat.comCarnegie Investment Counsel Boosts Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)Carnegie Investment Counsel raised its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 25.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 376,910 shares of the company's stock after buying an additional 76,650 shares during theJanuary 17 at 5:52 AM | marketbeat.comCHURCHILL MANAGEMENT Corp Purchases Shares of 18,392 Hims & Hers Health, Inc. (NYSE:HIMS)CHURCHILL MANAGEMENT Corp acquired a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 18,392 shares of the company's stock, valueJanuary 17 at 4:32 AM | marketbeat.comAxios Event: Improving public trust is key focus for health care industry, leaders sayJanuary 16, 2025 | msn.comHealth care execs feel optimistic about incoming Trump administrationJanuary 16, 2025 | msn.comIs Hims & Hers Stock in Trouble?January 16, 2025 | fool.comInvestors in Hims & Hers Health (NYSE:HIMS) have seen enviable returns of 440% over the past three yearsJanuary 15, 2025 | finance.yahoo.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $174,724.13 in StockJanuary 15, 2025 | insidertrades.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 7,259 Shares of StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Michael Chi sold 7,259 shares of the stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $24.07, for a total value of $174,724.13. Following the completion of the sale, the insider now directly owns 193,601 shares of the company's stock, valued at approximately $4,659,976.07. The trade was a 3.61 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.January 14, 2025 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) CFO Sells $283,039.64 in StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock in a transaction on Monday, January 13th. The shares were sold at an average price of $24.44, for a total value of $283,039.64. Following the completion of the sale, the chief financial officer now directly owns 118,077 shares of the company's stock, valued at $2,885,801.88. The trade was a 8.93 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.January 14, 2025 | marketbeat.comHims & Hers Health: Strong App Download Momentum and New Product Launches Drive Buy RecommendationJanuary 13, 2025 | markets.businessinsider.comHims & Hers Health (NYSE:HIMS) Cut to "Sell" at CitigroupJanuary 13, 2025 | americanbankingnews.comHims & Hers Health, Inc. (NYSE:HIMS) Receives $24.80 Consensus Target Price from AnalystsJanuary 13, 2025 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Shares Gap Down - Here's What HappenedHims & Hers Health (NYSE:HIMS) Shares Gap Down - Time to Sell?January 10, 2025 | marketbeat.comHims & Hers Stock Is Poised for a Major Surge in 2025January 10, 2025 | fool.comCiti downgrades Hims & Hers to Sell on valuation concernsJanuary 10, 2025 | markets.businessinsider.comHims & Hers downgraded to Sell from Neutral at CitiJanuary 10, 2025 | markets.businessinsider.comHims & Hers Health down as Citi downgrades on GLP-1 revenue stream overvaluationJanuary 10, 2025 | msn.comHims & Hers Health (NYSE:HIMS) Downgraded by Citigroup to "Sell"Citigroup lowered shares of Hims & Hers Health from a "neutral" rating to a "sell" rating and increased their price target for the stock from $24.00 to $25.00 in a research report on Friday.January 10, 2025 | marketbeat.comHims & Hers Health (NYSE:HIMS) Earns Buy Rating from Analysts at BTIG ResearchJanuary 10, 2025 | americanbankingnews.comHims & Hers Health, Inc. (NYSE:HIMS) Given Consensus Recommendation of "Hold" by BrokeragesHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) has earned an average rating of "Hold" from the seventeen analysts that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and eight hJanuary 10, 2025 | marketbeat.comDon't Buy Hims & Hers Stock If You Want Better Than Mediocre ReturnsJanuary 9, 2025 | seekingalpha.comHere’s Cedar Grove Capital Management’s Investment Thesis for Hims & Hers Health (HIMS)January 9, 2025 | msn.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 268,932 Shares of StockJanuary 8, 2025 | insidertrades.comHims & Hers initiated with a Buy at BTIGJanuary 8, 2025 | markets.businessinsider.comEven Hims & Hers is giving Trump moneyJanuary 8, 2025 | yahoo.comBTIG Initiates Coverage of Hims & Hers Health (HIMS) with Buy RecommendationJanuary 8, 2025 | msn.comSoleil Boughton Sells 268,932 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 268,932 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of $27.75, for a total transaction of $7,462,863.00. Following the completion of the sale, the insider now owns 169,803 shares in the company, valued at $4,712,033.25. The trade was a 61.30 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.January 7, 2025 | marketbeat.comHims & Hers donates $1 million to Trump's inauguration fundJanuary 7, 2025 | cnbc.comHims & Hers price target raised to $24 from $21 at Piper SandlerJanuary 7, 2025 | markets.businessinsider.comHims donates to Trump's inaugural committeeJanuary 7, 2025 | msn.comWhat 12 Analyst Ratings Have To Say About Hims & Hers HealthJanuary 7, 2025 | benzinga.comBTIG Research Initiates Coverage on Hims & Hers Health (NYSE:HIMS)BTIG Research initiated coverage on Hims & Hers Health in a research note on Tuesday. They issued a "buy" rating and a $35.00 price objective on the stock.January 7, 2025 | marketbeat.comHims & Hers Health (NYSE:HIMS) Stock Price Expected to Rise, Piper Sandler Analyst SaysPiper Sandler raised their price objective on shares of Hims & Hers Health from $21.00 to $24.00 and gave the stock a "neutral" rating in a report on Monday.January 6, 2025 | marketbeat.comHims & Hers Health: Undervalued Growth Potential Amidst Digital Health ExpansionJanuary 6, 2025 | markets.businessinsider.comHims & Hers Health (NYSE:HIMS) Given New $31.00 Price Target at Needham & Company LLCNeedham & Company LLC lifted their target price on Hims & Hers Health from $28.00 to $31.00 and gave the stock a "buy" rating in a report on Monday.January 6, 2025 | marketbeat.comJPMorgan Chase & Co. Sells 504,044 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)JPMorgan Chase & Co. lessened its position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 19.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,050,122 shares of the company's stock after selling 504,044January 6, 2025 | marketbeat.comHims & Hers: Ready For Liftoff In 2025January 2, 2025 | seekingalpha.com Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address HIMS Media Mentions By Week HIMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIMS News Sentiment▼0.540.45▲Average Medical News Sentiment HIMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIMS Articles This Week▼2415▲HIMS Articles Average Week Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NTRA News Today FMS News Today OPCH News Today GH News Today RDNT News Today SHC News Today BTSG News Today VCYT News Today LFST News Today CON News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HIMS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
